Eyeworld

Contact Name: Contact Holland: eholland@holprovision.com Miller: kmiller@ucla.edu ASCRS NEWS T he inaugural ASCRS Cataract Day will take place on Monday, May 18 at the ASCRS Annual Meeting in Boston, Massachu- setts. Based on attendee feedback, this full day of program- ming will be focused entirely on cataract surgery. Led by the Cataract Clinical Committee, ASCRS Cataract Day is designed to provide real-world cases, practical information, and video instruction for anterior segment surgeons at all experience levels. To increase attendee engagement, sessions will include audience response questions and answers, panel discussions, analysis, and high- lights of key findings from the ASCRS Clinical Surveys. Kevin M. Miller, MD, ASCRS Cataract Clinical Committee chair, helped plan parts of Cataract Day, which he said is a concentrated way for attendees to get all the latest information on cataract surgery in one place. The first session will cover "Cataract Surgery Essentials: Surviving and Thriving in the Clinic and Operation Room." Dr. Miller called it "the stuff you need to know to perform refractive cataract surgery right now." The session will feature data from the 2019 ASCRS Clinical Sur- vey and will include presentations on astigmatism, toric IOLs, handling posterior capsule rupture and vitreous loss, and more. The early afternoon session will focus on advanced cataract sur- gery, expanding on topics from the first session of the day. Dr. Miller said it will cover topics such as complications and management and poor outcomes. Cataract Day will conclude with the popular ASCRS Cataract Surgery Olympics, which features four international teams of cataract surgeons competing in a video session, highlighting practical pearls for routine and complicated cataract surgery. "If someone wanted to get the A to Z of cataract, they would want to think about parking themselves in the Cataract Day ballroom and staying all day," Dr. Miller said. "Most of our ASCRS members consider cataract surgery to be their most important surgical procedure," said Edward Holland, MD, ASCRS program chair. "The concept for ASCRS Cataract Day is to provide a dedi- cated day of cataract education that delivers a comprehensive overview and update on the various aspects of cataract surgery—di- agnostics, surgical techniques, new IOLs, and complication management. The pro- gram committee thinks members will find this an efficient and valuable experience in their cataract education." 12 | EYEWORLD | MARCH 2020 Cataract Day added to Monday program at ASCRS Annual Meeting AcrySof ® IQ PanOptix ® Family of Trifocal IOLs Important Product Information CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. INDICATIONS: The AcrySof ® IQ PanOptix ® Trifocal IOLs include AcrySof ® IQ PanOptix ® and AcrySof ® IQ PanOptix ® Toric IOLs and are indicated for primary implantation in the capsular bag in the posterior chamber of the eye for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. In addition, the AcrySof ® IQ PanOptix ® Toric Trifocal IOL is indicated for the reduction of residual refractive astigmatism. WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia and ensure that IOL centration is achieved. For the AcrySof ® IQ PanOptix ® Toric Trifocal IOL, the lens should not be implanted if the posterior capsule is ruptured, if the zonules are damaged or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction. If necessary, lens repositioning should occur as early as possible prior to lens encapsulation. Some visual effects may be expected due to the superposition of focused and unfocused multiple images. These may include some perceptions of halos or starbursts, as well as other visual symptoms. As with other multifocal IOLs, there is a possibility that visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. A reduction in contrast sensitivity as compared to a monofocal IOL may be experienced by some patients and may be more prevalent in low lighting conditions. Therefore, patients implanted with multifocal IOLs should exercise caution when driving at night or in poor visibility conditions. Patients should be advised that unexpected outcomes could lead to continued spectacle dependence or the need for secondary surgical intervention (e.g., intraocular lens replacement or repositioning). As with other multifocal IOLs, patients may need glasses when reading small print or looking at small objects. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than patients with monofocal IOLs. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure, available from Alcon, informing them of possible risks and benefits associated with the AcrySof ® IQ PanOptix ® Trifocal IOLs. ATTENTION: Reference the Directions for Use labeling for each IOL for a complete listing of indications, warnings and precautions. © 2019 Alcon Inc. 8/19 US-ACP-1900043 CATARACT DAY Sponsored by the ASCRS Cataract Clinical Committee

• Blank Page
• Blank Page (1)